1. Annual Report 2025
  2. Research
  3. QiSP-Tar

QiSP-Tar

Tarragona Quality and Patient Safety research group

The QiSP-Tar group is a multidisciplinary group that brings together members who work together in the field of quality and patient safety in primary care and with great impact on the whole community.

L'equip investigador està format per professionals de la Unitat de Qualitat de la Gerència territorial del Camp de tarragona de l'Institut Català de la Salut, de la USR de Tarragona, del departament de Salut de la generalitat de Catalunya i de la Sociedad Española of Family and Community Medicine (SemFYC). The team as a whole has sufficient solidity in the quality and safety of patients and previous experience in research. In addition, different members of the team present a strong collaboration with experts in this sector at national and international level.

The group has funding from both internal calls from the IDIAP Jordi Gol and external competitive calls (Instituto de Salud Carlos III, Academy of Medical Sciences) and an active agreement with the Department of Health of the generality of Catalonia.
The main objective of the group is to promote research in quality and patient safety with the aim of providing safe and quality care to citizens.

Group projects

  • INSIGNIA Project. An initiative to improve the follow-up of patients with Chronic Obstructive Pulmonary Disease. AstraZeneca Farmacéutica Spain, S.A. 2022-2025. PI: Francisco Martín Luján.

  • Evaluation of SINERGIAPS, an intervention aimed at improving patient safety in health centers in Spain based on the perceptions and experiences of the patients themselves. 2023-2026. PI: Montserrat Gens Barberà.

  • Evaluation of the efficacy of 2 Audit & Feedback interventions to reduce the potentially inappropriate prescription of medication and the prescription of antibiotics in primary care. AIMab Study: Multicenter clinical trial. (PI22/01669). Carlos III Health Institute. 2024-2026. PI: Ferran Bejarano Romero.

  • Evaluation of patient safety in primary care in Spain based on the perceptions and experiences of the patients themselves: SINERGIAPS 2 study. (PI22/01822). Carlos III Health Institute. 2022-2026. PI: Montserrat Gens Barberà.

  • Efficiency of an online training in cardiopulmonary and external automatic defibrillator (AED) maneuvers through a virtual platform. 2023-2026. PI: Cristina Rey Reñones.

  • Effectiveness of a mobile app in smoking cessation in pregnant women (TOBBGEST): a randomized community trial. (PI21/01058). Carlos III Health Institute. 2021-2026. PI: Cristina Rey Reñones.

  • Effect of the Mediterranean Diet on lung function in smokers with a common respiratory pathology: the MEDIS-TAR (Mediterranean Diet and Smoking in Tarragona) clinical assaig. COL· LEGI OFICIAL DE METGES DE TARRAGONA. 2023-2026. PI: Francisco Martín Luján.

  • Consume and experience with tobacco during the embaràs. Estudi qualitatiu. 2023-2026. PI: Cristina Rey Reñones.

  • Intensification ISCIII Cristina Rey. (INT23/00021). Carlos III Health Institute. 2023IP: Cristina Rey Reñones.

  • Effectiveness of a motivational intervention based on spirometry results to achieve smoking cessation in primary healthcare patients: randomised, parallel, controlled multicentre study. COL· OFFICIAL COLLEGE OF PHYSICIANS OF TARRAGONA. PI: Francisco Martín Luján.

  • Evaluation of synergies, an intervention aimed at improving patient safety in health centers in Spain based on the perceptions and experiences of the patients themselves. Agency for the Management of Univ and Research Grants (AGAUR). 2024-2027. IP: Georgina Vidal Mansilla.

  • Integration of the primary care pharmacist/pharmacologist in the primary care team. 2024IP: Ferran Bejarano Romero.

  • App for smoking cessation therapy. TOBBSTOP. Viladecans Style Oulet - VTSO. PI: Cristina Rey Reñones.

Group publications

  •  Luján FM, Alberich RS. The usefulness of studying visceral fat for early stratification of atherogenic risk: from conventional anthropometry to more accurate measurements. Clin. Invest. Arterioscler. 2025;37(6):500874-500874. PMID:41276337.

  • Fortuny DB, López SR, Martínez Torres S, Rey Reñones C, Martín Luján FM. The Influence of Virtual Reality Glasses Use on the Quality of Life of Older Adults: Protocol for a Prospective, Longitudinal Quasi-Experimental Study. JMIR RES. Protoc. 2025;14PMID:41432992.

  • Pedret Llaberia R, Basora Gallisà T, Martínez Torres S, Rodríguez Soler S, Pallejà Millán M, Buscemi A et al. Social and Demographic Determinants of Health: A Descriptive Study on the Impact of Place of Residence and Community Belonging. Healthcare. 2025;13(10): PMID:40427962.

  • de Diego Cabanes C, Torras Vives V, Vila Córcoles A, Satué Gracia EM, Forcadell Peris MJ, Gómez Bertomeu F et al. Real world effectiveness of antipneumococcal vaccination against pneumonia in adults: a population-based cohort study, Catalonia, 2019. BMC Infect. Dis. 2025;25(1):1369-1369. PMID:41120971.

  • Clua Espuny JL, Hernández Pinilla A, Gentille Lorente D, Muria Subirats E, Forcadell Arenas T, de Diego Cabanes C et al. Evidence Gaps and Lessons in the Early Detection of Atrial Fibrillation: A Prospective Study in a Primary Care Setting (PREFATE Study). Biomedicines. 2025;13(1): PMID:39857703.

  • Fiol de Roque MA, Valderas JM, Serrano Ripoll MJ, Gens Barbarà M, Martín Luján F, Sánchez Freire E et al. Evaluating SinergiAPS, an intervention based on patient feedback to improve patient safety in primary care: a cluster randomized trial. BMC Med. 2025;23(1):202-202. PMID:40189506.

  • Romero FB, Molés VA, Porrúa DM, Guerrero EL, Barriga HS, Vilarrasa LC. Effectiveness of GLP-1 receptor agonists in managing patients with type 2 diabetes. Aten. Prim. 2025;57(11):103354-103354. PMID:40925137.

  • Hernández Vidal N, Pujol Vidal M, Mengíbar García Y, Ayala Villuendas D, Contel Segura JC, Martínez Torres S et al. Design, Implementation, and Evaluation of Healthcare Visual Map Tool for Health Workers to Improve Quality of Life of Home Care Patients: Study Protocol. Healthcare. 2025;13(6): PMID:40150476.

  • Seguí DR, Forcadell MJ, Vila Córcoles A, De Diego Cabanes C, Ochoa Gondar O, Lujan FM et al. Classification rule for ten year MACE Risk in primary care tarragona older adults with type2 diabetes: a CHAID decision-tree analysis. BMC Prim. Care. 2025;26(1):129-129. PMID:40281435.

  • Motevalizadeh E, Díaz López A, Jardí C, Rey Reñones C, Martín Luján F, Arija V. Cardiometabolic Markers Associated With Altered Fetal Growth in Mediterranean Cohort. Matern. Child Nutr. 2025;21(4): PMID:40767273.

  • Soler A, Huguet A, Leiva A, Vicens C, Bejarano Romero F, Sempere E et al. A pharmacist-led educational and audit & feedback strategy to reduce antibiotic prescription in primary care: the AFA study. BMC Prim. Care. 2025;26(1): PMID:40684119.

  • Pinilla AH, Clua Espuny JL, Satue Gracia E, Martin Lujan FM, Gentille Lorente D, Palleja Millan M et al. Proactive atrial fibrillation screening in primary care: assessing the impact of a device-based approach. Eur. Heart J. 2025;46.

Anar a l'inici